Skip to Main Content

Author Details

Julia M Akeroyd
Section of Health Services Research, Baylor College of Medicine
2013
47
17
PMIDPaper TitleJournal TitlePublished Year
36702340Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD.Am J Kidney Dis2023
37231800Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.Am J Nephrol2023
36871214Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease.Circulation2023
33400053Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.Cardiovasc Drugs Ther2022
33523335Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System.Cardiovasc Drugs Ther2022
35015080Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.Diabetes Care2022
34799356Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort.Clin J Am Soc Nephrol2022
32880803Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System.Cardiovasc Drugs Ther2021
34950914Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease.Am J Prev Cardiol2021
34666951Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system.J Clin Lipidol2021
34074952Health care costs associated with primary care physicians versus nurse practitioners and physician assistants.J Am Assoc Nurse Pract2021
32161052Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database.Diabetes Care2020
31896038Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system.Am Heart J2020
31952841Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System).Am J Cardiol2020
33170055Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.J Am Heart Assoc2020
32840709Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.Cardiovasc Drugs Ther2020
30636483Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease.Circ Cardiovasc Qual Outcomes2019
31501043The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs.J Clin Lipidol2019
31405545Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System).Am J Cardiol2019
31370962Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines.J Am Coll Cardiol2019
30865483Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial.Circulation2019
31005521Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease.JACC Cardiovasc Imaging2019
31103643Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System.Am J Med2019
30586689Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial.Circulation2019
28994631Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care.Popul Health Manag2018
29957606Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease.JAAPA2018
29949816Incorporating Guideline Adherence and Practice Implementation Issues into the Design of Decision Support for Beta-Blocker Titration for Heart Failure.Appl Clin Inform2018
30498000Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.Clin J Am Soc Nephrol2018
29748356Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol â¿¥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.Circ Cardiovasc Qual Outcomes2018
29600737Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.Vasc Med2018
29374801Premature Coronary Heart Disease in South Asians: Burden and Determinants.Curr Atheroscler Rep2018
28841246Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.Clin Cardiol2017
28465286Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs.Circulation2017
27054163A dataset to assess providers׳ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline.Data Brief2016
27823696Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act.Am Heart J2016
27206936Provider understanding of the 2013 ACC/AHA cholesterol guideline.J Clin Lipidol2016
27497507Cholesterol Guidelines: More Similar Than Different.Prog Cardiovasc Dis2016
27553104Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.Am J Cardiol2016
26773472Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline.Atherosclerosis2016
27059708Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.Clin Cardiol2016
25456865Gender disparities in evidence-based statin therapy in patients with cardiovascular disease.Am J Cardiol2015
26483105Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry.J Am Coll Cardiol2015
26730300Adherence to cardiovascular medications in the South Asian population: A systematic review of current evidence and future directions.World J Cardiol2015
26071828Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.Am J Med2015
24973938Differences in skeletal and non-skeletal factors in a diverse sample of men with and without type 2 diabetes mellitus.J Diabetes Complications2014
25324147Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines.Clin Cardiol2014
23773471Composite restorations may lead to increased concentrations of salivary and urinary BPA.J Evid Based Dent Pract2013
  • 1 - 47 of 47

Recommended Authors

Center for Outcomes Research and Evaluation, Yale New Haven Hospital
Career Start Year 2017
Number of shared co-authors 4
Kaiser Permanente Southern California
Career Start Year 2017
Number of shared co-authors 0
Cardiovascular medicine clinical fellow at the Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 4
Department of Medicine Stanford University Stanford CA USA.
Career Start Year 2015
Number of shared co-authors 5
Department of Cardiovascular Medicine Mayo Clinic Rochester MN.
Career Start Year 2014
Number of shared co-authors 0
Yale University School of Medicine & Yale New Haven Hospital
Career Start Year 2013
Number of shared co-authors 6
Yale School of Medicine
Career Start Year 2009
Number of shared co-authors 11
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 4
Harvard Medical School
Career Start Year 2006
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 4
Ralph H. Johnson Veterans Affairs Healthcare System.
Career Start Year 2004
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 2
University of Florida College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 5
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City
Career Start Year 2001
Number of shared co-authors 13
Rutgers University Institute for Health, the State University of New Jersey
Career Start Year 2001
Number of shared co-authors 3
Duke Clinical Research Institute
Career Start Year 1999
Number of shared co-authors 11
University of California-San Francisco
Career Start Year 1998
Number of shared co-authors 6
Yale School of Medicine
Career Start Year 1998
Number of shared co-authors 9
Duke University
Career Start Year 1997
Number of shared co-authors 1
University of Texas Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 14
Cork University Hospital
Career Start Year 1993
Number of shared co-authors 6
and Blood Institute
Career Start Year 1991
Number of shared co-authors 9
Tulane University School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Weill Cornell Medical Center
Career Start Year 1990
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 1988
Number of shared co-authors 14
University of Massachusetts Medical School
Career Start Year 1987
Number of shared co-authors 2
Fielding School of Public Health, University of California los angeles
Career Start Year 1981
Number of shared co-authors 0
Kaiser Permanente Northern California
Career Start Year 1962
Number of shared co-authors 16

Collaborators

Baylor College of Medicine
Co-authored papers 45
Michael E. DeBakey VA Medical Center
Co-authored papers 38
Baylor College of Medicine
Co-authored papers 35
Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine
Co-authored papers 23
Center for Health Data Science and Analytics
Co-authored papers 13
Baylor College of Medicine
Co-authored papers 13
Section of Health Services Research, Baylor College of Medicine
Co-authored papers 13
Baylor College of Medicine
Co-authored papers 10
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 9
Feinberg School of Medicine, Northwestern University
Co-authored papers 8
Baylor College of Medicine
Co-authored papers 7
Baylor College of Medicine
Co-authored papers 6
Co-authored papers 6
Selzman Institute for Kidney Health, Baylor College of Medicine
Co-authored papers 6
Michael E DeBakey VA Medical Center
Co-authored papers 6
Vanderbilt University Medical Center
Co-authored papers 6
Baylor College of Medicine
Co-authored papers 5
Brigham and Women's Hospital
Co-authored papers 3
UTHealth School of Public Health
Co-authored papers 3
Washington University School of Medicine
Co-authored papers 3
Selzman Institute for Kidney Health, Baylor College of Medicine
Co-authored papers 3
NYU Langone Health and NYU School of Medicine
Co-authored papers 3
Center for Immersive & Simulation-based Learning, Stanford School of Medicine
Co-authored papers 2
UT Southwestern Medical Center
Co-authored papers 2
Stanford University School of Medicine
Co-authored papers 2
Department of Veterans Affairs Clinical Assessment
Co-authored papers 2
Brown University Alpert Medical School
Co-authored papers 2
Section of Health Services Research, Baylor College of Medicine
Co-authored papers 2
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1